Operating capital runway sufficient into the fourth quarter of 2026 In-person Type C FDA meeting scheduled by end of the first quarter of 2026 to discuss the latest CNM-Au8 data submitted in late ...
Operating capital runway sufficient into the fourth quarter of 2026 In-person Type C FDA meeting scheduled by end of the first quarter of 2026 to discuss the latest CNM-Au8 data submitted in late 2025 ...
A study by researchers at UTHealth Houston concludes that fetoscopic ablation is an alternative treatment for select cases of vasa previa. The findings were published in Ultrasound in Obstetrics & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results